Cargando…
Inhibitory Control Deficits Associated with Upregulation of CB(1)R in the HIV-1 Tat Transgenic Mouse Model of Hand
In the era of combined antiretroviral therapy, HIV-1 infected individuals are living longer lives; however, longevity is met with an increasing number of HIV-1 associated neurocognitive disorders (HAND) diagnoses. The transactivator of transcription (Tat) is known to mediate the neurotoxic effects i...
Autores principales: | Jacobs, Ian R., Xu, Changqing, Hermes, Douglas J., League, Alexis F., Xu, Callie, Nath, Bhupendra, Jiang, Wei, Niphakis, Micah J., Cravatt, Benjamin F., Mackie, Ken, Mukhopadhyay, Somnath, Lichtman, Aron H., Ignatowska-Jankowska, Bogna M., Fitting, Sylvia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6898753/ https://www.ncbi.nlm.nih.gov/pubmed/31372820 http://dx.doi.org/10.1007/s11481-019-09867-w |
Ejemplares similares
-
Inhibitory Neurotransmission Is Sex-Dependently Affected by Tat Expression in Transgenic Mice and Suppressed by the Fatty Acid Amide Hydrolase Enzyme Inhibitor PF3845 via Cannabinoid Type-1 Receptor Mechanisms
por: Xu, Changqing, et al.
Publicado: (2022) -
Monoacylglycerol Lipase Inhibitor MJN110 Reduces Neuronal Hyperexcitability, Restores Dendritic Arborization Complexity, and Regulates Reward-Related Behavior in Presence of HIV-1 Tat
por: League, Alexis F., et al.
Publicado: (2021) -
GPR18 drives FAAH inhibition-induced neuroprotection against HIV-1 Tat-induced neurodegeneration
por: Hermes, Douglas J., et al.
Publicado: (2021) -
Escalating morphine dosing in HIV-1 Tat transgenic mice with sustained Tat exposure reveals an allostatic shift in neuroinflammatory regulation accompanied by increased neuroprotective non-endocannabinoid lipid signaling molecules and amino acids
por: Hermes, Douglas J., et al.
Publicado: (2020) -
Inhibition of GABAergic Neurotransmission by HIV-1 Tat and Opioid Treatment in the Striatum Involves μ-Opioid Receptors
por: Xu, Changqing, et al.
Publicado: (2016)